prost
Prostaglandins and drugs that mimic them.
- Drugs containing prost: 28
- Approved somewhere: 12
- With a US drug page: 12
- Stem
- prost
- Class
- Prostaglandins and drugs that mimic them
- Sub-stems
- -prostil
Approved and clinical-stage drugs in ChEMBL whose names containing prost or one of its sub-stems, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Alprostadil | Approved | PTGER1, PTGER2 | Prostanoid EP1 receptor agonist |
| Bimatoprost | Approved | PTGFR | Prostanoid FP receptor agonist |
| Epoprostenol | Approved | PTGIR | Prostanoid IP receptor agonist |
| Iloprost | Approved | PTGIR | Prostanoid IP receptor agonist |
| Latanoprost | Approved | PTGFR | Prostanoid FP receptor agonist |
| Latanoprostene bunod | Approved | PTGFR | Prostanoid FP receptor agonist |
| Lubiprostone | Approved | CLCN2 | Chloride channel protein 2 opener |
| Misoprostol | Approved | PTGER3 | Prostanoid EP3 receptor agonist |
| Tafluprost | Approved | PTGFR | Prostanoid FP receptor agonist |
| Travoprost | Approved | PTGFR | Prostanoid FP receptor agonist |
| Dinoprostone | Phase 3 | Prostaglandin E2 receptor | Prostaglandin E2 receptor agonist |
| Unoprostone isopropyl | Phase 3 | — | Unknown |
| Carboprost | Approved | PTGFR | Prostanoid FP receptor agonist |
| Treprostinil | Approved | PTGIR | Prostanoid IP receptor agonist |
| Beraprost | Phase 3 | — | — |
| Ecraprost | Phase 3 | — | — |
| Esuberaprost | Phase 3 | PTGIR | Prostanoid IP receptor agonist |
| Limaprost | Phase 3 | — | — |
| Bimatoprost grenod | Phase 2 | — | — |
| Cobiprostone | Phase 2 | CLCN2 | Chloride channel protein 2 activator |
| Gemeprost | Phase 2 | — | — |
| Rivenprost | Phase 2 | PTGER4 | Prostanoid EP4 receptor agonist |
| Unoprostone | Phase 2 | — | — |
| Treprostinil palmitil | Phase 1 | — | — |
| Treprostinil phosphate | Phase 1 | — | — |
| Dinoprost | — | PTGFR | Prostanoid FP receptor agonist |
| Sepetaprost | — | PTGER3, PTGFR | Prostanoid EP3 receptor agonist |
| Enprostil | Phase 2 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO